Liraglutide Improves Zinc Signaling and Mitochondrial Function in Insulin-Resistant Cells
Liraglutide modulated intracellular zinc release and improved mitochondrial bioenergetics in insulin-resistant hepatocyte models, revealing a novel mechanism through zinc-mitochondria crosstalk.
Quick Facts
What This Study Found
Liraglutide modulated zinc release and improved mitochondrial bioenergetics in insulin-resistant hepatocytes, revealing zinc-mitochondria crosstalk as a novel GLP-1 drug mechanism.
Key Numbers
How They Did This
In vitro insulin-resistant hepatocyte models treated with liraglutide, with intracellular zinc dynamics measurement and mitochondrial bioenergetic profiling.
Why This Research Matters
Understanding how GLP-1 drugs improve cellular energy production through zinc signaling reveals new therapeutic targets and explains metabolic benefits beyond glucose/appetite effects.
The Bigger Picture
Zinc-mitochondria crosstalk may be a fundamental mechanism linking metabolic disease, aging, and GLP-1 drug benefits.
What This Study Doesn't Tell Us
In vitro hepatocyte models. Cannot determine clinical significance of zinc modulation. Single GLP-1 drug tested.
Questions This Raises
- ?Does zinc supplementation enhance GLP-1 drug effectiveness?
- ?Is zinc-mitochondria crosstalk relevant in other tissues (muscle, brain)?
- ?Could zinc status predict GLP-1 drug response?
Trust & Context
- Key Stat:
- Zinc → mitochondria link Liraglutide improves mitochondrial function through zinc signaling modulation — a previously unknown GLP-1 drug mechanism
- Evidence Grade:
- In vitro mechanistic study. Novel finding requiring in vivo validation.
- Study Age:
- Published in 2025.
- Original Title:
- Liraglutide Modulates Zinc Release and Improves Mitochondrial Function in Insulin-Resistant Senescent Cardiomyocytes.
- Published In:
- Cardiovascular toxicology, 26(2), 22 (2026)
- Authors:
- Hosseinpourshirazi, Fatemeh, Mendes, Umur D, Aksoy, Zeynep B, Aydos, Dunya, Sözer, Merve, Aljaser, Lubne, Gundogdu, Manolya, Sık, Suatnur, Tuncay, Erkan, Turan, Belma, Olgar, Yusuf
- Database ID:
- RPEP-15310
Evidence Hierarchy
Frequently Asked Questions
How does liraglutide improve cell energy?
This study found liraglutide modulates zinc levels inside cells, which in turn improves how mitochondria (cellular power plants) produce energy. This zinc-mitochondria connection is a newly discovered mechanism.
Should I take zinc with GLP-1 drugs?
This is too early to recommend. The study shows zinc plays a role in how GLP-1 drugs work at the cellular level, but whether zinc supplements would enhance drug effects needs further study.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15310APA
Hosseinpourshirazi, Fatemeh; Mendes, Umur D; Aksoy, Zeynep B; Aydos, Dunya; Sözer, Merve; Aljaser, Lubne; Gundogdu, Manolya; Sık, Suatnur; Tuncay, Erkan; Turan, Belma; Olgar, Yusuf. (2026). Liraglutide Modulates Zinc Release and Improves Mitochondrial Function in Insulin-Resistant Senescent Cardiomyocytes.. Cardiovascular toxicology, 26(2), 22. https://doi.org/10.1007/s12012-026-10095-x
MLA
Hosseinpourshirazi, Fatemeh, et al. "Liraglutide Modulates Zinc Release and Improves Mitochondrial Function in Insulin-Resistant Senescent Cardiomyocytes.." Cardiovascular toxicology, 2026. https://doi.org/10.1007/s12012-026-10095-x
RethinkPeptides
RethinkPeptides Research Database. "Liraglutide Modulates Zinc Release and Improves Mitochondria..." RPEP-15310. Retrieved from https://rethinkpeptides.com/research/hosseinpourshirazi-2026-liraglutide-modulates-zinc-release
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.